Top 4 Stocks In The Drug Delivery Industry With The Highest Gross Margin (BVF, ALKS, MTXX, NKTR)
Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of gross margin.
The trailing-twelve-month gross margin at Biovail Corporation (NYSE: BVF) stands at 73.22%. BVF’s quarterly revenue growth is 26.70% y/y.
The trailing-twelve-month gross margin at Alkermes Inc (NASDAQ: ALKS) stands at 72.27%. Analysts at Jesup & Lamont initiated coverage of ALKS with a “buy” rating.
The trailing-twelve-month gross margin at Matrixx Initiatives Inc (NASDAQ: MTXX) stands at 69.27%. GG’s shares fell 3.06% over the past 52 weeks, while the S&P 500 index gained 16.67% in the same period.
The trailing-twelve-month gross margin at Nektar Therapeutics (NASDAQ: NKTR) stands at 68.97%. NKTR’s quarterly revenue growth is 242.30% y/y.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
